[Predictive value of the tumor marker combination CA-125 and beta-2-microglobulin in ovarian cancer].

@article{Herndi1992PredictiveVO,
  title={[Predictive value of the tumor marker combination CA-125 and beta-2-microglobulin in ovarian cancer].},
  author={Zolt{\'a}n Hern{\'a}di and Val{\'e}ria Moln{\'a}r and B{\'e}la Juh{\'a}sz and R P{\'o}lka and B Margitai},
  journal={Zentralblatt fur Gynakologie},
  year={1992},
  volume={114 1},
  pages={6-9}
}
Beta-2-Microglobulin (b2m) and or Ca-125 levels were measured in 367 serum samples of 66 ovarian cancer patients. CA-125 was found to be a suitable tool, even in single use, to monitorise the clinical course of the disease with acceptable sensitivity (o. 89) and specificity (o. 94). B2m showed a sensitivity of the same level (o. 87) the specificity of it however proved to be low (o. 48). In consequence of its low specificity the b2m as a single marker is not applicable in ovarian cancer… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…